...
首页> 外文期刊>BMC Nephrology >Factors affecting the relationship between ionized and corrected calcium levels in peritoneal dialysis patients: a retrospective cross-sectional study
【24h】

Factors affecting the relationship between ionized and corrected calcium levels in peritoneal dialysis patients: a retrospective cross-sectional study

机译:影响腹膜透析患者电离和校正钙水平关系的因素:回顾性横截面研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Chronic kidney disease-mineral and bone disorder (CKD-MBD) management in patients with end-stage renal disease is important owing to the risk of cardiovascular diseases. In clinical practice, we manage patients not by monitoring the levels of biologically active ionized calcium (iCa) but by monitoring total serum calcium or corrected calcium (cCa). We previously reported that iCa/cCa ratio was different between patients with hemodialysis and those with peritoneal dialysis (PD). In PD patients, several factors are expected to affect iCa/cCa ratio. Therefore, modifying the strategy to achieve better CKD-MBD management might be necessary; however, no reports have studied this to date. Therefore, we investigated the factors influencing iCa/cCa ratio in PD patients. This retrospective cross-sectional study examined background and laboratory data, including iCa, collected at routine outpatient visits. The patients were divided into the first, second, and third tertile of iCa/cCa ratio groups to compare patient background and laboratory data. Multiple regression analysis was used to investigate the factors influencing iCa/cCa ratio. We used multiple imputation to deal with missing covariate data. In total, 169 PD patients were enrolled. In PD patients with lower iCa/cCa ratio, PD duration was longer and pH was higher. Urine volume and weekly renal Kt/V were lower in the patients with lower iCa/cCa ratio than in those with higher iCa/cCa ratio. iCa/cCa ratio and weekly renal Kt/V were directly correlated (r?=?0.41, p??0.01), and weekly renal Kt/V and pH were independent factors affecting iCa/cCa ratio (t?=?2.86, p??0.01 and t?=???5.42, p??0.01, respectively). iCa levels were lower in PD patients with lower residual renal function (RRF) even though their cCa levels were equal to those with maintained RRF, warranting caution in the assessment and management of CKD-MBD in PD patients.
机译:由于心血管疾病的风险,延期肾病患者的慢性肾病 - 矿物和骨紊乱(CKD-MBD)管理是重要的。在临床实践中,我们通过监测生物活性电离钙(ICA)的水平来管理患者,而是通过监测总血清钙或矫正钙(CCA)。我们之前报道,血液透析患者和腹膜透析(PD)的患者之间的ICA / CCA比例不同。在PD患者中,预计几个因素会影响ICA / CCA比率。因此,可能需要修改策略以实现更好的CKD-MBD管理;但是,迄今为止没有报告。因此,我们调查了影响PD患者ICA / CCA比率的因素。此回顾性横截面研究检查了在常规门诊访问时收集的ICA的背景和实验室数据。将患者分为ICA / CCA比例的第一,第二和第三条,以比较患者背景和实验室数据。使用多元回归分析来研究影响ICA / CCA比率的因素。我们使用多个贷款来处理缺少的协变量数据。共有169名PD患者。在ICA / CCA比率较低的PD患者中,PD持续时间更长,pH值较高。尿量和每周肾KT / v较低的ICA / CCA比率较低的患者患者比具有更高的ICA / CCA比的患者。 ICA / CCA比和每周肾KT / V直接相关(R?= 0.41,P?<β01)和每周肾KT / V和pH是影响ICA / CCA比率的独立因素(T?= 2.86, p?<?0.01和t?= ??? 5.42,p?<Δ01)。在残留肾功能较低的PD患者中,ICA水平降低,即使其CCA水平等于维持RRF的CCA水平,谨慎在PD患者中的CKD-MBD评估和管理中的要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号